Skip to main content
logo
Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India flag India · Delayed Price · Currency is INR
13.99
-0.99 (-6.61%)
At close: Sep 22, 2026

BOM:531015 Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
92.9480.258.07---
Revenue Growth
385.68%894.04%----
Gross Profit
8.557.410.12-0.1--
Operating Income
1.951.40.05-1.12-1.94-1.36
Net Income
3.272.48-0.110.652.2618.46
Earnings Per Share
0.240.21-0.020.120.433.52
EPS Growth
691.80%---72.09%-87.78%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
8.2262.3624.820.0300
Total Debt
2.113.310.53.523.523.49
Net Cash (Debt)
6.1159.0624.33-3.5-3.52-3.49
Net Cash Growth
-75.26%142.75%----
Net Cash Per Share
0.465.104.64-0.67-0.67-0.67

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-121.44-109.96-22.90.02-0.0319.05
Capital Expenditures
-0.06-----
Free Cash Flow
-121.5-109.96-22.90.02-0.0319.05
Free Cash Flow Growth
-----621.97%

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
9.20%9.23%1.52%---
Operating Margin
2.10%1.75%0.58%---
Pretax Margin
3.83%3.45%-1.75%---
Profit Margin
3.52%3.09%-1.30%---
FCF Margin
-130.73%-137.03%-283.69%---

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
57.25120.26----
PS Ratio
1.743.7218.51---